Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oogenesis02:07

Oogenesis

68.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.8K
Oogenesis01:22

Oogenesis

3.6K
Oogenesis,  the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
3.6K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

6.3K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
6.3K
Ovarian Cycle01:27

Ovarian Cycle

3.3K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Ala307Thr polymorphism of the follicle-stimulating hormone receptor (FSHR) gene is associated with the dose of recombinant FSH received during IVF/ICSI treatment.

JBRA assisted reproduction·2023
Same author

Covid-19 school closures negatively impacted elementary-school students' reading comprehension and reading fluency skills.

International journal of educational development·2023
Same author

MSOME/IMSI versus epigenetic marks: doubts in the past for hopes in the future.

JBRA assisted reproduction·2022
Same author

The effects of age on sperm quality: an evaluation of 1,500 semen samples.

JBRA assisted reproduction·2022
Same author

Administration of progesterone on the day of oocyte retrieval to reverse accumulation of fluid in the endometrial cavity during assisted reproductive techniques.

JBRA assisted reproduction·2022
Same author

Correlation of TP53 (rs1625895), TP73 (rs3765730), MMP9 (rs17576), and MTHFR (rs868014) polymorphisms with low ovarian reserve.

European journal of obstetrics, gynecology, and reproductive biology·2021

Related Experiment Video

Updated: Jan 9, 2026

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

4.9K

Options for Final Oocyte Maturation Trigger: Can the Ovarian Response Prediction Index (ORPI) Guide the Optimal

Jose G Franco Junior1, Claudia G Petersen1, Joao Bosco Meziara1

  • 1Center for Human Reproduction Prof. Franco Jr - Ribeirão Preto, SP, Brazil.

JBRA Assisted Reproduction
|December 10, 2025
PubMed
Summary

Dual triggering, using both GnRH agonist and hCG, is recommended for final oocyte maturation in IVF patients undergoing GnRH antagonist protocols. This approach may improve key reproductive outcomes like embryo quality and clinical pregnancy rates.

Keywords:
ORPIdual triggeroocyte maturation

More Related Videos

Whole Ovary Immunofluorescence, Clearing, and Multiphoton Microscopy for Quantitative 3D Analysis of the Developing Ovarian Reserve in Mouse
12:36

Whole Ovary Immunofluorescence, Clearing, and Multiphoton Microscopy for Quantitative 3D Analysis of the Developing Ovarian Reserve in Mouse

Published on: September 3, 2021

5.3K
Analysis of Chromosome Segregation, Histone Acetylation, and Spindle Morphology in Horse Oocytes
12:11

Analysis of Chromosome Segregation, Histone Acetylation, and Spindle Morphology in Horse Oocytes

Published on: May 11, 2017

11.3K

Related Experiment Videos

Last Updated: Jan 9, 2026

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

4.9K
Whole Ovary Immunofluorescence, Clearing, and Multiphoton Microscopy for Quantitative 3D Analysis of the Developing Ovarian Reserve in Mouse
12:36

Whole Ovary Immunofluorescence, Clearing, and Multiphoton Microscopy for Quantitative 3D Analysis of the Developing Ovarian Reserve in Mouse

Published on: September 3, 2021

5.3K
Analysis of Chromosome Segregation, Histone Acetylation, and Spindle Morphology in Horse Oocytes
12:11

Analysis of Chromosome Segregation, Histone Acetylation, and Spindle Morphology in Horse Oocytes

Published on: May 11, 2017

11.3K

Area of Science:

  • Reproductive Endocrinology
  • In Vitro Fertilization (IVF)

Background:

  • GnRH antagonists are commonly used in IVF to prevent premature ovulation.
  • Dual triggering (GnRH agonist + hCG) is increasingly considered for final oocyte maturation.

Purpose of the Study:

  • To evaluate the efficacy and optimal application of dual triggering in IVF cycles using GnRH antagonists.
  • To assess the impact of dual triggering on oocyte maturation, embryo quality, and clinical pregnancy rates.

Main Methods:

  • Review of recent meta-analyses and clinical data on dual triggering protocols.
  • Analysis of outcomes across different ranges of ovarian response (ORPI) with varying hCG dosages.
  • Consideration of luteal phase support strategies in conjunction with dual triggering.

Main Results:

  • Recent meta-analyses suggest dual triggering improves oocyte maturation, embryo quality, and clinical pregnancy rates.
  • Dual triggering is recommended for most patients in GnRH antagonist cycles, including those with varying ovarian responses (ORPI ranges A-D).
  • Careful clinical assessment is crucial when combining GnRH agonist with low-dose hCG for luteal phase support, potentially necessitating a freeze-all protocol.

Conclusions:

  • Dual triggering is a preferred method for final oocyte maturation in IVF patients undergoing GnRH antagonist protocols.
  • The benefits of dual triggering extend to improved reproductive outcomes, supporting its consideration across different ovarian response levels.
  • Specific protocols, including freeze-all, should be considered when managing luteal phase support with combined GnRH agonist and low-dose hCG triggers.